Companies · Healthtech

Q Care International Llc

MARIETTA · Healthtech · refined from filed group “Other Health Care

Diligence memoA one-page analyst read on Q Care International Llc — recommendation, valuation, rhythm, risks.
$10.7M
Total raised · real
3
Rounds
1.0×
Latest step-up
Top 30%
Sector rank · raised
Seed
Latest stage · inferred · Thu Feb 20 1997 00:00:00 GMT+0000 (Coordinated Universal Time)

Q Care International Llc has raised $11M over 3 rounds; too few niche peers to rank its valuation yet.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the healthtech sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Dormant
  • Last raise 29.4 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.

Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.

Issuer-vehicle patternmedium confidence

Q Care International Llc behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.

Issuer structure
Company-like
No recurring-offering pattern strong enough to override normal financing interpretation.
Lifecycle
29.4 yr record
Peak capital year was 1997 with $28.7M across 8 filings.
Market position
ahead of 71% of Healthtech peers
Capital scale is ahead of 71% of Healthtech peers; modeled value is above 77% of peers by modeled value. Large capital with mid-pack modeled value can signal an issuer/program profile rather than operating-company growth.
Valuation reliability
Normal applicability
Stage/dilution valuation models are weakest when the issuer is broad-sector, recurring, or vehicle-like.
Operating evidence
Sparse
No clear CEO/founder/principal role is surfaced, so operating-company confidence is lower.
Data quality
Needs review
Row-level filing totals differ from canonical totals, so amendment/superseded filtering should be checked.
What triggered this
  • Legal name looks like an issuer vehicle rather than a product company.
  • No clearly named CEO/founder/principal role in the public records surfaced here.
  • No verified homepage on the profile yet.
  • Capital program peaked in 1997: $28.7M across 8 filings.
  • Largest single filing was $3.9M on 1997-02-20.
  • Filing rows sum to $28.7M, while canonical raised total is $10.7M; likely amendments/superseded rows are mixed into the detail view.
How to read the page
  • Read this less like a startup funding journey and more like a capital-raising program.
  • Stage-based valuation and peer labels have lower applicability for this pattern.
  • The more important signal is lifecycle: repeated filings ended years ago, so current activity needs outside confirmation.
  • Canonical filtering should be tightened before using row-level totals for diligence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Healthtech

Q Care International Llc is one of 2138 Healthtech companies tracked from MARIETTA. By capital raised it ranks in the upper tier (ahead of 71% of sector peers), and in the upper tier by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
49
Investors (latest)
1997-02-20
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$50M$100M$150M$200MSeed · 1997-02-20 Raised $3.9M (real) Modeled valuation $107M (est)Seed1997Seed · 1997-02-20 Raised $3.9M (real) Modeled valuation $107M (est)Seed1997Seed · 1997-02-20 Raised $2.6M (real) Modeled valuation $73M (est)Seed1997Seed · 1997-02-20 Raised $3.8M (real) Modeled valuation $105M (est)Seed1997Seed · 1997-02-20 Raised $3.0M (real) Modeled valuation $85M (est)Seed1997Seed · 1997-02-20 Raised $3.9M (real) Modeled valuation $107M (est)Seed1997Seed · 1997-02-20 Raised $3.9M (real) Modeled valuation $107M (est)Seed1997Seed · 1997-02-20 Raised $3.9M (real) Modeled valuation $107M (est)Seed1997+$3.9M+$2.6M+$3.8M+$3.0M+$3.9M+$3.9M+$3.9MCumulative $29M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Seed$3.9M · 1997
Seed extension$3.9M · 1997
Seed extension$2.6M · 1997
Seed extension$3.8M · 1997
Seed extension$3.0M · 1997
Seed extension$3.9M · 1997
Seed extension$3.9M · 1997
Seed extension$3.9M · 1997

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 50%.

Modeled valuation trajectory
$106.8M
Base estimate est.
$3.3M
Conservative case
$837.6M
Upside case
$19.3M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Seeda $1.0M–$4.0M round). Valuation is modeled from stage benchmarks scaled by the healthtech sector profile. Directional, not a quoted figure.

Seed · modeled $106.8M · 1997-02-201997Seed · modeled $106.8M · 1997-02-20Seed · modeled $73.1M · 1997-02-20Seed · modeled $105.4M · 1997-02-20Seed · modeled $84.6M · 1997-02-20Seed · modeled $106.8M · 1997-02-20Seed · modeled $106.8M · 1997-02-20Seed · modeled $106.8M · 1997-02-201997
Model inputs · modeled:benchmark-stage-stepup-v1
20%
Dilution assumption
Implied ownership sold in the financing.
38%
Survival probability
17% low · 58% high
1.57×/yr
Annual markup
2.05×/yr upside case
6.0 yr
Elapsed time used
29.4 yr actual, capped for stale marks
healthtech
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
0 mo
Avg between rounds
Capital velocity
29.4 yr
On record since
1997
First round
8
Rounds on file
How it compares to the market

Benchmarked against 2138 companies in Healthtech. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 2.4× above median
This company$10.7M
Sector median$4.5M
Latest round — vs other Seed rounds in sector (real $, this stage) 2.0× above median
This company$3.9M
Sector median$1.9M
Modeled value — vs sector median (estimate, all stages) 3.2× above median
This company$106.8M
Sector median$33.8M

Raised more than 71% of sector peers (real $). Modeled value above 77% of peers (estimate).

Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Seed$3.9M1997-02-20$19.3M$106.8M90%
Seed$3.9M1997-02-20$19.3M$106.8M85%
Seed$2.6M1997-02-20$13.2M$73.1M85%
Seed$3.8M1997-02-20$19.0M$105.4M85%
Seed$3.0M1997-02-20$15.3M$84.6M85%
Seed$3.9M1997-02-20$19.3M$106.8M90%
Seed$3.9M1997-02-20$19.3M$106.8M90%
Seed$3.9M1997-02-20$19.3M$106.8M85%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Seed$3.9M1997-02-20
    • First recorded raise — entered as Seed.
    • 49 investors on this round.
  2. Seed$3.9M1997-02-20
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
    • 49 investors on this round.
  3. Seed$2.6M1997-02-20
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 1.5× smaller than the prior — bridge or down round.
    • Switched to Rule 06 (was Rule 506(b)).
    • 100 investors on this round.
  4. Seed$3.8M1997-02-20
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 1.4× larger than the prior — scaling up.
    • Switched to Rule 506(b) (was Rule 06).
    • 49 investors on this round.
  5. Seed$3.0M1997-02-20
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
    • Switched to Rule 06 (was Rule 506(b)).
    • 100 investors on this round.
  6. Seed$3.9M1997-02-20
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
    • Switched to Rule 506(b) (was Rule 06).
    • 49 investors on this round.
  7. Seed$3.9M1997-02-20
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
    • 49 investors on this round.
  8. Seed$3.9M1997-02-20
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
    • 49 investors on this round.
Intelligence
Modeled next raise
$3.9M
Modeled next size est.range $3.9M$6.2M
1.0×
Last step-up
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
E.L. F. COX1997-02
Michael F. Cox1997-02
Paul F. Yokubinas1997-02
Robert F Singley1997-02
William F. Butler1997-02
Registry & provenance

Q Care International Llc is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1034485
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Titan Medical IncHealthtechSeed$10.0M$63.0Msame sector · same stage
Cecelia Health, Inc.HealthtechSeed$11.8M$71.1Msame sector · same stage
Broad Axe Care Coordination LlcHealthtechSeed$8.4M$61.0Msame sector · same stage
Shadow Health, Inc.HealthtechSeed$8.0M$83.2Msame sector · same stage
HealthPrize Technologies, LLCHealthtechSeed$14.4M$83.1Msame sector · same stage
Metric Medical Devices, Inc.HealthtechSeed$8.0M$81.9Msame sector · same stage
Jumo Health, Inc.HealthtechSeed$7.5M$60.5Msame sector · same stage
PhyzData Healthcare Solutions, LLCHealthtechSeed$6.8M$69.3Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Q'Apel Medical, Inc.HealthtechSeries B$123.3M87%
Interstate Health Systems, Inc.HealthtechSeed$20.8M86%
What About Health, Inc.HealthtechPre-Seed$7.6M86%
Worldwide Innovative Healthcare Inc.HealthtechPre-Seed$9.5M86%
Qview Medical, Inc.HealthtechSeries A$45.1M86%
Health Care Solutions Inc.HealthtechSeed$26.8M85%
Care One Services LLCHealthtechPre-Seed$7.8M85%
WELL Health Technologies Corp.HealthtechSeed$92.8M85%
Frequently asked
How much funding has Q Care International Llc raised?
Q Care International Llc has raised approximately $10.7M in disclosed capital across 3 recorded financing rounds, aggregated from public filings.
What is Q Care International Llc's estimated valuation?
Provath's modeled valuation for Q Care International Llc is approximately $106.8M (modeled range $3.3M–$837.6M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Q Care International Llc at?
Q Care International Llc's latest modeled financing stage is Seed. Its most recent recorded round closed around Thu Feb 20.
What does Q Care International Llc do and where is it based?
Q Care International Llc operates in the Healthtech sector, based in MARIETTA.
Explore related

See where Q Care International Llc sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Q Care International Llc, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.